Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2 - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Science Immunology Année : 2021

Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2

Résumé

Human γδ T cells contribute to tissue homeostasis and participate in epithelial stress surveillance through mechanisms that are not well understood. Here, we identified ephrin type-A receptor 2 (EphA2) as a stress antigen recognized by a human Vγ9Vδ1 TCR. EphA2 is recognized coordinately by ephrin A to enable γδ TCR activation. We identified a putative TCR binding site on the ligand-binding domain of EphA2 that was distinct from the ephrin A binding site. Expression of EphA2 was up-regulated upon AMP-activated protein kinase (AMPK)-dependent metabolic reprogramming of cancer cells, and coexpression of EphA2 and active AMPK in tumors was associated with higher CD3 T cell infiltration in human colorectal cancer tissue. These results highlight the potential of the human γδ TCR to cooperate with a co-receptor to recognize non-MHC-encoded proteins as signals of cellular dysregulation, potentially allowing γδ T cells to sense metabolic energy changes associated with either viral infection or cancer.

Domaines

Cancer
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03349495 , version 1 (20-09-2021)

Identifiants

Citer

Christelle Harly, Stephen Paul, Charlotte Domblides, Thomas Bachelet, Vincent Pitard, et al.. Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2. Science Immunology, 2021, 6 (61), pp.eaba9010. ⟨10.1126/sciimmunol.aba9010⟩. ⟨inserm-03349495⟩
46 Consultations
16 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More